Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 172,590 | 225,508 | 282,092 | 221,099 | 214,182 |
| Cost of Goods | 99,606 | 122,918 | 167,322 | 127,550 | 129,331 |
| Gross Profit | 72,984 | 102,590 | 114,770 | 93,549 | 84,851 |
| Operating Expenses | 69,189 | 65,557 | 84,288 | 66,540 | 67,129 |
| Operating Income | 4,401 | 37,951 | 30,804 | 27,559 | 18,053 |
| Interest Expense | 8,454 | 8,331 | 7,116 | 8,182 | 6,953 |
| Other Income | 103 | -47,114 | -10,399 | 41,955 | -15,648 |
| Pre-tax Income | -3,950 | -17,494 | 13,289 | 61,332 | -4,548 |
| Income Tax | -1,249 | -7,086 | 1,862 | 25,577 | -2,696 |
| Net Income Continuous | -2,701 | -10,408 | 11,427 | 35,755 | -1,852 |
| Net Income | $-2,701 | $-10,408 | $11,427 | $35,755 | $-1,852 |
| EPS Basic Total Ops | -0.04 | -0.15 | 0.17 | 0.51 | -0.03 |
| EPS Basic Continuous Ops | -0.04 | -0.15 | 0.17 | 0.51 | -0.03 |
| EPS Diluted Total Ops | -0.04 | -0.15 | 0.17 | 0.49 | -0.03 |
| EPS Diluted Continuous Ops | -0.04 | -0.15 | 0.17 | 0.49 | -0.03 |
| EBITDA(a) | $25,100 | $53,671 | $50,777 | $46,437 | $37,397 |